» Articles » PMID: 4025385

Noonan Syndrome: the Changing Phenotype

Overview
Journal Am J Med Genet
Specialty Genetics
Date 1985 Jul 1
PMID 4025385
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Among the multiple congenital anomalies (MCA) syndromes, the Noonan syndrome (NS) is a cardiofacial syndrome in which affected individuals may be short and mildly mentally retarded. Autosomal dominant inheritance of Noonan syndrome with variable expressivity has been documented in many families. Genetic heterogeneity has been postulated in Noonan syndrome because of the wide phenotypic variability, the relatively high incidence, and the occasional recurrence in sibs with apparently normal parents. Clinical variability is usual in autosomal dominant disorders, and mildly affected individuals may be difficult to recognize as gene carriers. Thus, a family with two or more affected children may simulate autosomal recessive inheritance. We have studied serial and family photographs of NS individuals in order to assess the likelihood of gene carriers' being missed in genetic studies. We have confirmed wide clinical variability within families, and more importantly, we have documented marked change of phenotype with age from the newborn period, infancy, childhood, and adolescence to adulthood. Manifestations in adults may be subtle and some without a known heart defect or other medically significant problems may have been considered normal in the past. Our study, while not ruling out causal heterogeneity, suggests that the change of phenotype with age may have been falsely perceived as clinical heterogeneity. A particular and subtle phenotype must be searched for in parents of affected children.

Citing Articles

Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling-a Singaporean experience.

Chin H, Mei Lam J, Christopher D, Michelle P, Junrong B Front Oncol. 2023; 13:1182639.

PMID: 37860182 PMC: 10582742. DOI: 10.3389/fonc.2023.1182639.


RAF-1 Mutation Associated with a Risk for Ventricular Arrhythmias in a Child with Noonan Syndrome and Cardiovascular Pathology.

Fagarasan A, Al Hussein H, Ghiragosian Rusu S J Crit Care Med (Targu Mures). 2022; 8(2):126-130.

PMID: 35950157 PMC: 9097645. DOI: 10.2478/jccm-2022-0007.


LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.

Farncombe K, Thain E, Barnett-Tapia C, Sadeghian H, Kim R BMC Med Genomics. 2022; 15(1):160.

PMID: 35840934 PMC: 9288044. DOI: 10.1186/s12920-022-01304-x.


Cardiovascular Abnormalities and Gene Mutations in Children With Noonan Syndrome.

Sun L, Xie Y, Wang S, Zhang Z Front Genet. 2022; 13:915129.

PMID: 35770001 PMC: 9234298. DOI: 10.3389/fgene.2022.915129.


Refractory thrombocytopenia could be a rare initial presentation of Noonan syndrome in newborn infants: a case report and literature review.

Tang X, Chen Z, Shen X, Xie T, Wang X, Liu T BMC Pediatr. 2022; 22(1):142.

PMID: 35300644 PMC: 8928670. DOI: 10.1186/s12887-021-02909-4.